The key factors added in this report will help leading players modify their manufacturing and marketing strategies to maximize their business growth in the coming years. Major competitors along with innovative analysis of their current developments, core competencies, product portfolio and investments in each segment are highlighted in the report. On the basis of the application type and geography, the head and neck cancer drug report splits the market size by volume and value. This report also considers the changes and advancements taking place in the global market. This research report will give clear idea to readers about the overall market scenario to further decide on this market project.
Global head and neck cancer drug market is rise gradually to an estimated value of USD 2.59 Billion by 2026 registering a CAGR of 8.1% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients.
Interested in this report? Get an Exclusive Sample Report Now https://databridgemarketresearch.com/request-a-sample/?dbmr=global-head-and-neck-cancer-drug-market
According to the published article in American Society of Clinical Oncology in Jan 2019, it is identified that there are 65,410 cases of head and neck cancer, of which 48,000 are men and 17,410 are women. It is estimated that 14,620 patients will be dying from this disease in the current year. This significant rise in patient number acts as a driver for the growth of head and cancer drugs.
Leading major competitors currently working in the Head and neck cancer drug Cancer market are AstraZeneca Plc , Immutep, Fortress Biotech, F. Hoffmann-La Roche Ltd, Pfizer Inc., Merck KGaA, Bristol-Myers Squibb Company, Novartis AG, Merck & Co., Inc., Eli Lilly and Company, Regeneron Pharmaceuticals, Inc. and few among others.
Market Drivers
- Increase in prevalence rate of Head and neck cancer worldwide
- Chronic consumption of Tobacco products and alcohol
- Rising awareness about treatment and technological advancement is driving the growth of market
- Increase in the rate of R&D initiatives is driving Head and neck Cancer therapeutics market
Market Restraints
- High cost involved in the treatment
- Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market
- Lack of awareness among the patient and physician about head and neck treatment
Key Developments in the Market:
In September 2018, Regeneron Pharmaceuticals, Inc. received FDA approval of Libtayo (cemiplimab-rwlc) for the treatment of patient with head and neck cancer or advanced squamous cell carcinoma. Libtaya is PD-1 (protein found on the body’s immune cells and some cancer cells) blocking antibody. The recommended dose of LIBTAYO is 350 mg given by intravenous infusion over 30 minutes every 3 weeks.
In April 2019, Merck & Co., Inc. got FDA expanded label approval of KEYTRUDA (pembrolizumab) for the treatment of recurrent or metastatic head and neck squamous cell carcinoma. It is given after the administration of platinum containing chemotherapy. Keytruda is anti PD-1 antibodies that act as immunomodulatory agent.
Know the answer to all your doubts of Head and neck cancer drug Market report@ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-head-and-neck-cancer-drug-market
Segmentation: Global Head and Neck Cancer Drug Market
By Type
- Laryngeal and hypopharyngeal cancer
- Nasal cavity and paranasal sinus cancer
- Oral and oropharyngeal cancer
- Salivary gland cancer
- Nasopharyngeal cancer
- Others
By Drug Type
- Carboplatin
- Cisplatin
- Docetaxel
- Paclitaxel
- 5-fluorouracil
- Epirubicin
- Immunomodulators
- Others
By Treatment
- Medication
- Chemotherapy
- Radiation therapy
- Immunotherapy
- Targeted Therapy
- Surgery
By Route of administration
- Oral
- Injectable
By End users
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Geography
- North America
- South America
- Europe
- Asia-Pacific
- Middle East & Africa
Avail 25% Instant Discount At https://www.databridgemarketresearch.com/request-a-discount/global-head-and-neck-cancer-drug-market
Market Drivers
Increase in prevalence rate of Head and neck cancer worldwide
Chronic consumption of Tobacco products and alcohol
Rising awareness about treatment and technological advancement is driving the growth of market
Increase in the rate of R&D initiatives is driving Head and neck Cancer therapeutics market
Table of Contents:
Executive Summary
Scope/opportunities of the Report
Research Methodology
Market Landscape
Pipeline Analysis
Market Sizing
Porter’s Five Forces Analysis
Market Segmentation
Customer Landscape
Regional Landscape
Business Decision Framework
Drivers And Challenges
Market Key Trends
Players Landscape
Players Analysis
Appendix
Get Detail TOC@ https://databridgemarketresearch.com/toc/?dbmr=global-head-and-neck-cancer-drug-market
Benefits of Report Purchase from Data Bridge Market Research:
Detailed Research
We provide accurate data and in-depth analysis with all-inclusive coverage.
Robust Research Methodology
Robust research methodology and data triangulation to ensure high quality report.
Analyst Support
24*7 analyst support – Pre and post purchase of the report as well as during the project tenure.
Sales Support
24*7 sales support – Hassle free delivery of the report and quick response and support by sales team.
Free Customization
20% post purchase free customization to meet your requirements.
Customer Satisfaction
We claim full customer satisfaction as our core values lie in building long term relationship.
Research Methodology: Global Head and neck cancer drug Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-head-and-neck-cancer-drug-market
The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
